149 related articles for article (PubMed ID: 7955150)
1. Allosteric enhancer PD 81,723 acts by novel mechanism to potentiate cardiac actions of adenosine.
Kollias-Baker C; Ruble J; Dennis D; Bruns RF; Linden J; Belardinelli L
Circ Res; 1994 Dec; 75(6):961-71. PubMed ID: 7955150
[TBL] [Abstract][Full Text] [Related]
2. Novel approach for enhancing atrioventricular nodal conduction delay mediated by endogenous adenosine.
Kollias-Baker C; Xu J; Pelleg A; Belardinelli L
Circ Res; 1994 Dec; 75(6):972-80. PubMed ID: 7955151
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of the adenosine A(1) receptor allosteric enhancer PD 81,723 on agonist binding to brain and adipocyte membranes.
Jarvis MF; Gessner G; Shapiro G; Merkel L; Myers M; Cox BF; Martin GE
Brain Res; 1999 Sep; 840(1-2):75-83. PubMed ID: 10517954
[TBL] [Abstract][Full Text] [Related]
4. A novel irreversible antagonist of the A1-adenosine receptor.
Srinivas M; Shryock JC; Scammells PJ; Ruble J; Baker SP; Belardinelli L
Mol Pharmacol; 1996 Jul; 50(1):196-205. PubMed ID: 8700113
[TBL] [Abstract][Full Text] [Related]
5. The cardiac effects of a novel A1-adenosine receptor agonist in guinea pig isolated heart.
Belardinelli L; Lu J; Dennis D; Martens J; Shryock JC
J Pharmacol Exp Ther; 1994 Dec; 271(3):1371-82. PubMed ID: 7996449
[TBL] [Abstract][Full Text] [Related]
6. Selective potentiation by an A1 adenosine receptor enhancer of the negative dromotropic action of adenosine in the guinea pig heart.
Amoah-Apraku B; Xu J; Lu JY; Pelleg A; Bruns RF; Belardinelli L
J Pharmacol Exp Ther; 1993 Aug; 266(2):611-7. PubMed ID: 8355194
[TBL] [Abstract][Full Text] [Related]
7. The amphiphilic peptide adenoregulin enhances agonist binding to A1-adenosine receptors and [35S]GTP gamma S to brain membranes.
Moni RW; Romero FS; Daly JW
Cell Mol Neurobiol; 1995 Aug; 15(4):465-93. PubMed ID: 8565049
[TBL] [Abstract][Full Text] [Related]
8. Agonist-independent effect of an allosteric enhancer of the A1 adenosine receptor in CHO cells stably expressing the recombinant human A1 receptor.
Kollias-Baker CA; Ruble J; Jacobson M; Harrison JK; Ozeck M; Shryock JC; Belardinelli L
J Pharmacol Exp Ther; 1997 May; 281(2):761-8. PubMed ID: 9152383
[TBL] [Abstract][Full Text] [Related]
9. PD 81,723, an allosteric enhancer of the A1 adenosine receptor, lowers the threshold for ischemic preconditioning in dogs.
Mizumura T; Auchampach JA; Linden J; Bruns RF; Gross GJ
Circ Res; 1996 Sep; 79(3):415-23. PubMed ID: 8781475
[TBL] [Abstract][Full Text] [Related]
10. Species differences in brain adenosine A1 receptor pharmacology revealed by use of xanthine and pyrazolopyridine based antagonists.
Maemoto T; Finlayson K; Olverman HJ; Akahane A; Horton RW; Butcher SP
Br J Pharmacol; 1997 Nov; 122(6):1202-8. PubMed ID: 9401787
[TBL] [Abstract][Full Text] [Related]
11. A1 adenosine receptor inhibition of cyclic AMP formation and radioligand binding in the guinea-pig cerebral cortex.
Alexander SP; Curtis AR; Kendall DA; Hill SJ
Br J Pharmacol; 1994 Dec; 113(4):1501-7. PubMed ID: 7889308
[TBL] [Abstract][Full Text] [Related]
12. Homologous desensitization of the A1-adenosine receptor system in the guinea pig atrioventricular node.
Dennis DM; Shryock JC; Belardinelli L
J Pharmacol Exp Ther; 1995 Mar; 272(3):1024-35. PubMed ID: 7891312
[TBL] [Abstract][Full Text] [Related]
13. Persistent activation by and receptor reserve for an irreversible A1-adenosine receptor agonist in DDT1 MF-2 cells and in guinea pig heart.
Zhang J; Belardinelli L; Jacobson KA; Otero DH; Baker SP
Mol Pharmacol; 1997 Sep; 52(3):491-8. PubMed ID: 9281612
[TBL] [Abstract][Full Text] [Related]
14. Modulation of atrioventricular nodal function by metabolic and allosteric regulators of endogenous adenosine in guinea pig heart.
Dennis DM; Raatikainen MJ; Martens JR; Belardinelli L
Circulation; 1996 Nov; 94(10):2551-9. PubMed ID: 8921800
[TBL] [Abstract][Full Text] [Related]
15. Midazolam selectively potentiates the A(2A) - but not A1- receptor--mediated effects of adenosine: role of nucleoside transport inhibition and clinical implications.
Seubert CN; Morey TE; Martynyuk AE; Cucchiara RF; Dennis DM
Anesthesiology; 2000 Feb; 92(2):567-77. PubMed ID: 10691246
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of muscarinic K+ current in guinea-pig atrial myocytes by PD 81,723, an allosteric enhancer of adenosine binding to A1 receptors.
Brandts B; Bünemann M; Hluchy J; Sabin GV; Pott L
Br J Pharmacol; 1997 Jul; 121(6):1217-23. PubMed ID: 9249260
[TBL] [Abstract][Full Text] [Related]
17. 1,3-Dipropyl-8-[2-(5,6-epoxy)norbornyl]xanthine, a potent, specific and selective A1 adenosine receptor antagonist in the guinea pig heart and brain and in DDT1MF-2 cells.
Belardinelli L; Shryock JC; Zhang Y; Scammells PJ; Olsson R; Dennis D; Milner P; Pfister J; Baker SP
J Pharmacol Exp Ther; 1995 Dec; 275(3):1167-76. PubMed ID: 8531078
[TBL] [Abstract][Full Text] [Related]
18. Guanine nucleotide and cation regulation of the binding of [3H]cyclohexyladenosine and [3H]diethylphenylxanthine to adenosine A1 receptors in brain membranes.
Goodman RR; Cooper MJ; Gavish M; Snyder SH
Mol Pharmacol; 1982 Mar; 21(2):329-35. PubMed ID: 6285169
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of N6-[3H]cyclohexyladenosine binding by carbamazepine.
Weir RL; Anderson SM; Daly JW
Epilepsia; 1990; 31(5):503-12. PubMed ID: 2401242
[TBL] [Abstract][Full Text] [Related]
20. The effects of saponin on the binding and functional properties of the human adenosine A1 receptor.
Cohen FR; Lazareno S; Birdsall NJ
Br J Pharmacol; 1996 Apr; 117(7):1521-9. PubMed ID: 8730749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
